| [1] |
Wright JH, Johnson MM, Shimizu-Albergine M, et al. Paracrine activation of hepatic stellate cells in platelet-derived growth factor C transgenic mice: evidence for stromal induction of hepatocellular carcinoma[J]. Int J Cancer, 2014, 134(4): 778-788.
|
| [2] |
Morimoto Y, Nouso K, Wada N, et al. Involvement of platelets in extrahepatic metastasis of hepatocellular carcinoma[J]. Hepatol Res, 2014, 44(14): E353-E359.
|
| [3] |
Zanetto A, Campello E, Spiezia L, et al. Cancer-associated thrombosis in cirrhotic patients with hepatocellular carcinoma[J]. Cancers (Basel), 2018, 10(11): 450.
|
| [4] |
Lavergne M, Janus-Bell E, Schaff M, et al. Platelet integrins in tumor metastasis: do they represent a therapeutic target?[J]. Cancers (Basel), 2017, 9(10): 133.
|
| [5] |
Zhuang M, Xin G, Wei Z, et al. Dihydrodiosgenin inhibits endothelial cell-derived factor Ⅷ and platelet-mediated hepatocellular carcinoma metastasis[J]. Cancer Manag Res, 2019, 11: 4871-4882.
|
| [6] |
Carr BI, Cavallini A, D'Alessandro R, et al. Platelet extracts induce growth, migration and invasion in human hepatocellular carcinoma in vitro[J]. BMC Cancer, 2014, 14: 43.
|
| [7] |
Bihari C, Rastogi A, Shasthry SM, et al. Platelets contribute to growth and metastasis in hepatocellular carcinoma[J]. APMIS, 2016, 124(9): 776-786.
|
| [8] |
Sie ZL, Li RY, Sampurna BP, et al. WNK1 kinase stimulates angiogenesis to promote tumor growth and metastasis[J]. Cancers (Basel), 2020, 12(3): 575.
|
| [9] |
Wojtukiewicz MZ, Sierko E, Hempel D, et al. Platelets and cancer angiogenesis nexus[J]. Cancer Metastasis Rev, 2017, 36(2): 249-262.
|
| [10] |
Semenov AV, Romanov YA, Loktionova SA, et al. Production of soluble P-selectin by platelets and endothelial cells[J]. Biochemistry (Mosc), 1999, 64(11): 1326-1335.
|
| [11] |
Lalor Patricia F, John H, Roy B, et al. Hepatic sinusoidal endothelium avidly binds platelets in an integrin-dependent manner, leading to platelet and endothelial activation and leukocyte recruitment[J]. Am J Physiol Gastrointest Liver Physiol, 2013, 304(5): G469-G478.
|
| [12] |
Gordon-Weeks AN, Lim SY, Yuzhalin AE, et al. Neutrophils promote hepatic metastasis growth through fibroblast growth factor 2-dependent angiogenesis in mice[J]. Hepatology, 2017, 65(6): 1920-1935.
|
| [13] |
Lorente L. New prognostic biomarkers of mortality in patients undergoing liver transplantation for hepatocellular carcinoma[J]. World J Gastroenterol, 2018, 24(37): 4230-4242.
|
| [14] |
Carloni V, Luong TV, Rombouts K. Hepatic stellate cells and extracellular matrix in hepatocellular carcinoma: more complicated than ever[J]. Liver Int, 2014, 34(6): 834-843.
|
| [15] |
Yoshida S, Ikenaga N, Liu SB, et al. Extrahepatic platelet-derived growth factor-β, delivered by platelets, promotes activation of hepatic stellate cells and biliary fibrosis in mice[J]. Gastroenterology, 2014, 147(6): 1378-1392.
|
| [16] |
Borkham-Kamphorst E, Stoll D, Gressner AM, et al. Inhibitory effect of soluble PDGF-beta receptor in culture-activated hepatic stellate cells[J]. Biochem Biophys Res Commun, 2004, 317(2): 451-462.
|
| [17] |
Maass T, Thieringer FR, Mann A, et al. Liver specific overexpression of platelet-derived growth factor-B accelerates liver cancer development in chemically induced liver carcinogenesis[J]. Int J Cancer, 2011, 128(6): 1259-1268.
|
| [18] |
Fatima S, Shi X, Lin Z, et al. 5-Hydroxytryptamine promotes hepatocellular carcinoma proliferation by influencing β-catenin[J]. Mol Oncol, 2016, 10(2): 195-212.
|
| [19] |
Yang Q, Yan C, Yin C, et al. Serotonin activated hepatic stellate cells contribute to sex disparity in hepatocellular carcinoma[J]. Cell Mol Gastroenterol Hepatol, 2017, 3(3): 484-499.
|
| [20] |
Cheng YQ, Wang K, Zhang XP, et al. Thrombocytopenia: A prognostic factor for hepatocellular carcinoma patients with portal vein tumor thrombus after hepatectomy[J]. J Gastroenterol Hepatol, 2019, 34(7): 1214-1221.
|
| [21] |
Hwang SJ, Luo JC, Li CP, et al. Thrombocytosis: A paraneoplastic syndrome in patients with hepatocellular carcinoma[J]. World J Gastroenterol, 2004, 10(17): 2472-2477.
|
| [22] |
Alberto Z, Marco S, Alessandro V, et al. Thromboelastometry hypercoagulable profiles and portal vein thrombosis in cirrhotic patients with hepatocellular carcinoma[J]. Dig Liver Dis, 2017, 49(4): 440-445.
|
| [23] |
Lin WF, Zhong MF, Zhang YR, et al. Prognostic role of platelet-to-lymphocyte ratio in hepatocellular carcinoma with different BCLC stages: A systematic review and Meta-analysis[J]. Gastroenterol Res Pract, 2018, 2018: 5670949.
|